S&P 500   3,376.29 (+1.28%)
DOW   27,896.34 (+0.76%)
QQQ   271.50 (+2.38%)
AAPL   449.76 (+2.80%)
MSFT   208.91 (+2.72%)
FB   260.71 (+1.79%)
GOOGL   1,505.20 (+1.67%)
AMZN   3,155.67 (+2.43%)
NVDA   454.73 (+4.78%)
CGC   17.40 (+2.65%)
BABA   255.51 (+2.85%)
TSLA   1,527.24 (+11.12%)
GE   6.61 (-1.78%)
MU   48.33 (+1.19%)
AMD   82.24 (+6.97%)
T   30.12 (-0.26%)
F   7.06 (-2.35%)
ACB   9.92 (-1.00%)
GILD   68.86 (+1.12%)
NFLX   479.79 (+2.75%)
DIS   130.63 (+0.11%)
BAC   26.47 (-1.67%)
BA   174.25 (-3.26%)
S&P 500   3,376.29 (+1.28%)
DOW   27,896.34 (+0.76%)
QQQ   271.50 (+2.38%)
AAPL   449.76 (+2.80%)
MSFT   208.91 (+2.72%)
FB   260.71 (+1.79%)
GOOGL   1,505.20 (+1.67%)
AMZN   3,155.67 (+2.43%)
NVDA   454.73 (+4.78%)
CGC   17.40 (+2.65%)
BABA   255.51 (+2.85%)
TSLA   1,527.24 (+11.12%)
GE   6.61 (-1.78%)
MU   48.33 (+1.19%)
AMD   82.24 (+6.97%)
T   30.12 (-0.26%)
F   7.06 (-2.35%)
ACB   9.92 (-1.00%)
GILD   68.86 (+1.12%)
NFLX   479.79 (+2.75%)
DIS   130.63 (+0.11%)
BAC   26.47 (-1.67%)
BA   174.25 (-3.26%)
S&P 500   3,376.29 (+1.28%)
DOW   27,896.34 (+0.76%)
QQQ   271.50 (+2.38%)
AAPL   449.76 (+2.80%)
MSFT   208.91 (+2.72%)
FB   260.71 (+1.79%)
GOOGL   1,505.20 (+1.67%)
AMZN   3,155.67 (+2.43%)
NVDA   454.73 (+4.78%)
CGC   17.40 (+2.65%)
BABA   255.51 (+2.85%)
TSLA   1,527.24 (+11.12%)
GE   6.61 (-1.78%)
MU   48.33 (+1.19%)
AMD   82.24 (+6.97%)
T   30.12 (-0.26%)
F   7.06 (-2.35%)
ACB   9.92 (-1.00%)
GILD   68.86 (+1.12%)
NFLX   479.79 (+2.75%)
DIS   130.63 (+0.11%)
BAC   26.47 (-1.67%)
BA   174.25 (-3.26%)
S&P 500   3,376.29 (+1.28%)
DOW   27,896.34 (+0.76%)
QQQ   271.50 (+2.38%)
AAPL   449.76 (+2.80%)
MSFT   208.91 (+2.72%)
FB   260.71 (+1.79%)
GOOGL   1,505.20 (+1.67%)
AMZN   3,155.67 (+2.43%)
NVDA   454.73 (+4.78%)
CGC   17.40 (+2.65%)
BABA   255.51 (+2.85%)
TSLA   1,527.24 (+11.12%)
GE   6.61 (-1.78%)
MU   48.33 (+1.19%)
AMD   82.24 (+6.97%)
T   30.12 (-0.26%)
F   7.06 (-2.35%)
ACB   9.92 (-1.00%)
GILD   68.86 (+1.12%)
NFLX   479.79 (+2.75%)
DIS   130.63 (+0.11%)
BAC   26.47 (-1.67%)
BA   174.25 (-3.26%)
Log in

NASDAQ:PETSPetmed Express Stock Price, Forecast & News

$31.98
-0.30 (-0.93 %)
(As of 08/12/2020 01:34 PM ET)
Add
Compare
Today's Range
$31.62
Now: $31.98
$32.31
50-Day Range
$30.73
MA: $34.65
$40.53
52-Week Range
$15.12
Now: $31.98
$42.88
Volume11,738 shs
Average Volume684,219 shs
Market Capitalization$648.30 million
P/E Ratio22.68
Dividend Yield3.46%
Beta0.64
PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes. It also sells food, beds, crates, stairs, strollers, and other pet supplies. The company sells its products through its Internet Website; telephone contact center; and direct mail/print through brochures and postcards. PetMed Express, Inc. was founded in 1996 and is headquartered in Delray Beach, Florida.
Read More
Petmed Express logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.0Community Rank: 1.5Dividend Strength: 0.8Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.99 out of 5 stars


Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryInternet Retail
Current SymbolNASDAQ:PETS
CUSIP71638210
Phone561-526-4444

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$284.13 million
Cash Flow$1.40 per share
Book Value$6.45 per share

Profitability

Net Income$25.85 million

Miscellaneous

Employees187
Market Cap$648.30 million
Next Earnings Date10/19/2020 (Estimated)
OptionableOptionable
$31.98
-0.30 (-0.93 %)
(As of 08/12/2020 01:34 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PETS News and Ratings via Email

Sign-up to receive the latest news and ratings for PETS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Petmed Express (NASDAQ:PETS) Frequently Asked Questions

How has Petmed Express' stock been impacted by COVID-19 (Coronavirus)?

Petmed Express' stock was trading at $25.95 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, PETS stock has increased by 23.9% and is now trading at $32.14.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Petmed Express?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Petmed Express in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Petmed Express
.

When is Petmed Express' next earnings date?

Petmed Express is scheduled to release its next quarterly earnings announcement on Monday, October 19th 2020.
View our earnings forecast for Petmed Express
.

How were Petmed Express' earnings last quarter?

Petmed Express Inc (NASDAQ:PETS) posted its quarterly earnings results on Monday, July, 20th. The company reported $0.39 earnings per share for the quarter, missing analysts' consensus estimates of $0.40 by $0.01. The business had revenue of $96.20 million for the quarter, compared to analyst estimates of $90.96 million. Petmed Express had a return on equity of 21.91% and a net margin of 9.41%. The firm's revenue was up 20.3% compared to the same quarter last year. During the same quarter last year, the firm posted $0.26 earnings per share.
View Petmed Express' earnings history
.

How often does Petmed Express pay dividends? What is the dividend yield for Petmed Express?

Petmed Express declared a quarterly dividend on Monday, July 20th. Investors of record on Friday, July 31st will be given a dividend of $0.28 per share on Friday, August 7th. This represents a $1.12 dividend on an annualized basis and a yield of 3.48%. The ex-dividend date is Thursday, July 30th.
View Petmed Express' dividend history
.

What price target have analysts set for PETS?

2 equities research analysts have issued 12 month price objectives for Petmed Express' stock. Their forecasts range from $20.00 to $31.00. On average, they anticipate Petmed Express' stock price to reach $25.50 in the next twelve months. This suggests that the stock has a possible downside of 20.7%.
View analysts' price targets for Petmed Express
.

Has Petmed Express been receiving favorable news coverage?

Headlines about PETS stock have been trending negative recently, according to InfoTrie. The research firm rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Petmed Express earned a news sentiment score of -2.2 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the immediate future.
View the latest news about Petmed Express
.

Who are some of Petmed Express' key competitors?

What other stocks do shareholders of Petmed Express own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Petmed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Gilead Sciences (GILD), Alibaba Group (BABA), Cisco Systems (CSCO), Netflix (NFLX), Micron Technology (MU), Verizon Communications (VZ) and Advanced Micro Devices (AMD).

Who are Petmed Express' key executives?

Petmed Express' management team includes the following people:
  • Mr. Menderes Akdag, CEO, Pres & Director (Age 58)
  • Mr. Bruce S. Rosenbloom, CFO & Treasurer (Age 50)
  • Ms. Alison Berges, Corp. Sec. & Gen. Counsel

What is Petmed Express' stock symbol?

Petmed Express trades on the NASDAQ under the ticker symbol "PETS."

Who are Petmed Express' major shareholders?

Petmed Express' stock is owned by many different institutional and retail investors. Top institutional investors include Prudential Financial Inc. (2.10%), Robeco Institutional Asset Management B.V. (1.74%), ProShare Advisors LLC (1.19%), WINTON GROUP Ltd (1.12%), Principal Financial Group Inc. (0.75%) and Raymond James Financial Services Advisors Inc. (0.65%). Company insiders that own Petmed Express stock include Bruce S Rosenbloom, Gian Fulgoni, Menderes Akdag and Robert C Schweitzer.
View institutional ownership trends for Petmed Express
.

Which major investors are selling Petmed Express stock?

PETS stock was sold by a variety of institutional investors in the last quarter, including Hancock Whitney Corp, Cairn Investment Group Inc., North Star Investment Management Corp., Principal Financial Group Inc., Profit Investment Management LLC, Fisher Asset Management LLC, Wedge Capital Management L L P NC, and Alberta Investment Management Corp. Company insiders that have sold Petmed Express company stock in the last year include Bruce S Rosenbloom, Gian Fulgoni, and Menderes Akdag.
View insider buying and selling activity for Petmed Express
.

Which major investors are buying Petmed Express stock?

PETS stock was bought by a variety of institutional investors in the last quarter, including Prudential Financial Inc., Robeco Institutional Asset Management B.V., ProShare Advisors LLC, Raymond James Financial Services Advisors Inc., Mackay Shields LLC, WINTON GROUP Ltd, Aigen Investment Management LP, and SG Americas Securities LLC.
View insider buying and selling activity for Petmed Express
.

How do I buy shares of Petmed Express?

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Petmed Express' stock price today?

One share of PETS stock can currently be purchased for approximately $32.14.

How big of a company is Petmed Express?

Petmed Express has a market capitalization of $651.54 million and generates $284.13 million in revenue each year. Petmed Express employs 187 workers across the globe.

What is Petmed Express' official website?

The official website for Petmed Express is www.1800petmeds.com.

How can I contact Petmed Express?

Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.

This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.